Corcept Therapeutics Incorporated (LON: 0I3Q)
London
· Delayed Price · Currency is GBP · Price in USD 66.07
-3.71 (-5.32%)
At close: Jan 31, 2025
Corcept Therapeutics Market Cap
Corcept Therapeutics has a market cap or net worth of 5.64 billion as of January 31, 2025. Its market cap has increased by 179.26% in one year.
Market Cap
5.64B
Enterprise Value
5.21B
Revenue
468.96M
Ranking
n/a
PE Ratio
53.82
Stock Price
66.07
Market Cap Chart
Since April 14, 2004, Corcept Therapeutics's market cap has increased from 154.68M to 5.64B, an increase of 3,546.75%. That is a compound annual growth rate of 18.86%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 175.43B |
| GSK plc | 57.21B |
| Haleon | 34.01B |
| Smith & Nephew | 9.00B |
| ConvaTec Group | 5.10B |
| Hikma Pharmaceuticals | 5.06B |
| HUTCHMED (China) | 1.92B |
| Oxford Nanopore Technologies | 1.38B |